1/40
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai |
|---|
No analytics yet
Send a link to your students to track their progress
Immune Defense Mechanisms of the Respiratory Tract
Multiple layers of defense that prevent microbes from entering and establishing infection.
Goblet cells
Cells that secrete mucus, which traps dust, bacteria, viruses, and particles.
Mucociliary escalator
A mechanism where cilia beat upward to move trapped microbes toward the throat for expulsion.
Lysozyme
An enzyme that breaks down bacterial cell walls.
Defensins
Antimicrobial peptides that kill microbes.
Surfactant
A substance that helps reduce surface tension in the lungs; contributes to antimicrobial defense.
Secretory IgA antibodies
Antibodies that prevent microbes from attaching to mucosal surfaces.
MALT
Mucosa-associated lymphoid tissue that monitors pathogens entering the upper respiratory tract.
Alveolar macrophages
Immune cells located in the lower respiratory tract that engulf and destroy inhaled microbes.
Streptococcus pneumoniae
A bacterial pathogen that is a common cause of severe pneumonia.
Symptoms of Pneumonia
Cough, fever, chills, shortness of breath, chest pain, productive cough with sputum.
Diagnosis Clues for Pneumonia
Crackling lung sounds and white shadows on chest x-ray.
Streptococcus pneumoniae Gram Status
Gram-positive diplococci.
Klebsiella pneumoniae Gram Status
Gram-negative rod.
Mycoplasma pneumoniae Gram Status
No cell wall.
Virulence Factors of S. pneumoniae
Polysaccharide capsule that prevents phagocytosis.
PPSV23
Vaccine containing 23 serotypes for pneumonia prevention.
PCV13
Conjugated vaccine containing 13 serotypes for pneumonia prevention.
Klebsiella pneumoniae Symptoms
Similar to pneumococcal pneumonia with tissue necrosis and abscesses.
Immunocompromised Individuals
Most susceptible group for Klebsiella pneumoniae infections.
Virulence Factors of Klebsiella pneumoniae
Capsule that interferes with phagocytosis.
Mycoplasma pneumoniae Symptoms
Usually mild, with persistent cough and fatigue.
Macrolides
Antibiotics effectively used against Mycoplasma pneumoniae due to its lack of cell wall.
Streptococcus pyogenes
Bacterial pathogen known as Group A strep causing strep throat.
Symptoms of Strep Throat
Sore throat, redness, fever, pus patches.
Lancefield Groups
Grouping based on cell wall carbohydrates, with Streptococcus pyogenes as Group A.
Virulence Factor M Protein
Prevents C3b opsonization and facilitates attachment in Streptococcus pyogenes.
Risk Factors for Influenza
High-risk groups include adults over 65, children under 5, and pregnant women.
Influenza A Characteristics
Most virulent strain causing pandemics, infects humans and animals.
Antigenic Drift
Small mutations in the virus leading to seasonal outbreaks.
Two Stages of Tuberculosis
Latent TB (LTBI) which is asymptomatic and Active TB which is contagious.
MDR-TB
Multidrug-resistant tuberculosis indicating resistance to multiple antibiotics.
Symptoms of Active TB
Chronic cough, respiratory spread, systemic illness.
Pathogenesis of TB
Inhalation into lungs, engulfment by macrophages, and formation of granulomas.
Normal Microbiota of Upper Respiratory Tract
Includes Staphylococcus aureus, Streptococcus, Haemophilus, and Neisseria.
Treatment for Bacterial Pneumonia
Depends on causative agent: antibiotics for bacterial; antifungals for fungal.
Inflammation in Lungs
Caused by all bacterial pathogens leading to cough, fever, and respiratory distress.
Complications of Streptococcus pneumoniae
Septicemia, endocarditis, and meningitis if the bacteria enter the bloodstream.
Non-cell wall among bacteria
Mycoplasma pneumoniae lacks a cell wall making penicillin ineffective.
Age Group Most Susceptible to Strep Throat
Children are typically more susceptible to Streptococcus pyogenes infections.
Function of Neuraminidase
Helps the influenza virus bud out of the cell and enter new host cells.